血液培养检测市场：依方法、产品、技术、应用、最终用户和地区划分

血液培养检测市场规模预计在 2025 年达到 65.4 亿美元，预计到 2032 年将达到 138.4 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 11.3%。

全球血液培养检测市场是诊断医疗保健产业的关键部分，也是检测和识别血液感染疾病、败血症和菌血症的关键。

血液培养检测是指从患者体内抽取血液样本，并在专门的培养基中进行培养，以检测血液中可能存在的致病微生物，例如细菌、真菌和酵母菌。随着技术的进步，这项诊断技术已显着发展，从传统的手动方法发展到自动化系统，从而提高了准确性、缩短了结果获取时间并改善了临床疗效。

该市场包括各种测试技术，如常规培养、自动化血液培养系统、分子诊断技术等。世界各地的医疗机构高度依赖血液培养测试，因为它为选择适当的抗生素治疗和患者管理策略提供了重要资讯。

医院内感染的增加、人们对败血症早期诊断认识的提高以及对抗生素管理计划的日益重视，使得血液培养检测成为现代医疗保健的重要工具。市场涉及诊断实验室、医院、血库和研究机构等各类相关人员，所有这些都推动了对可靠且高效的血液培养检测解决方案的需求不断增长。

市场动态

全球血液培养检测市场的成长受到多种重要因素的驱动，这些因素共同推动了其成长轨迹。主要驱动因素是全球血液感染疾病和败血症发病率的上升，这推动了对快速且准确的诊断解决方案的需求。医院内感染的日益流行，加上癌症治疗、器官移植和慢性疾病导致的免疫力缺乏患者的增加，正在创造巨大的市场需求。自动化血液培养系统的技术进步，使其检测时间更快、灵敏度更高，是关键的成长催化剂。

此外，日益增长的老年人口（老年人易感染疾病）以及外科手术数量的增加也促进了市场的成长。然而，市场中也存在一些限制因素，例如自动化血液培养系统及其维护的高成本，这可能会限制其在资源受限的医疗环境中的应用。血液培养程序的复杂性（需要熟练的实验室人员）以及污染导致假阳性结果的风险也带来了额外的挑战。诊断设备的严格监管要求以及传统培养方法的耗时性也可能阻碍市场的成长。

然而，快速分子诊断技术和就地检验解决方案的开发蕴藏着巨大的机会，这些技术能够在数小时内（而非数天内）得出结果。新兴市场医疗基础设施的不断扩张、医疗成本的不断上涨以及对个人化医疗日益增长的关注，都为市场拓展提供了巨大的机会。将人工智慧和机器学习融入血液培养系统以增强解读能力，以及开发能够同时检测多种病原体的多重检测平台，都为市场拓展提供了广阔的前景。

本次调查的主要特点

• 本报告对全球血液培养检测市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球血液培养检测市场的主要企业。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球血液培养检测市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球血液培养检测市场的各种策略矩阵更轻鬆地做出决策。

目录

第 1 章：调查目标与先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020-2032 年全球血液培养检测市场（依方法）

• 自动血液培养
• 常规/手动血液培养

5. 2020-2032 年全球血液培养检测市场（依产品划分）

• 消耗品（例如培养基、检测试剂套件/试剂、配件等）
• 设备（自动血液培养系统、实验室设备）
• 软体和服务

6. 2020-2032 年全球血液培养检测市场（依技术划分）

• 基于培养的技术（包括传统技术与树脂技术）
• 分子技术（NAAT、基于PCR的面板、微阵列）
• 蛋白质体学技术（MALDI-TOF、LC-MS）

7. 2020-2032 年全球血液培养检测市场（按应用）

• 细菌感染疾病（例如菌血症、败血症）
• 真菌感染疾病（例如真菌血症）
• 病菌感染

8. 全球血液培养检测市场（依最终用户划分），2020-2032 年

• 医院检查室
• 诊断实验室
• 学术和研究机构
• 其他（病理学实验室、细菌学实验室、独立研究实验室、门诊手术中心）

9. 2020-2032 年全球血液培养检测市场（按地区）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十章 竞争格局

• Becton, Dickinson and Company（BD）
• bioMerieux SA
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Roche Diagnostics
• Siemens Healthineers AG
• Abbott Laboratories
• Bruker Corporation
• T2 Biosystems Inc.
• Cepheid Inc.
• Luminex Corporation
• Merck KGaA（MilliporeSigma）
• Sartorius AG
• QIAGEN NV
• BioFire Diagnostics LLC

第 11 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十二章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Blood Culture Test Market is estimated to be valued at USD 6.54 Bn in 2025 and is expected to reach USD 13.84 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.

The global blood culture test market represents a critical segment within the diagnostic healthcare industry, serving as a cornerstone for detecting and identifying bloodstream infections, sepsis, and bacteremia.

Blood culture testing involves the collection of blood samples from patients and their cultivation in specialized media to detect the presence of pathogenic microorganisms, including bacteria, fungi, and yeasts that may be circulating in the bloodstream. This diagnostic methodology has evolved significantly with technological advancements, transitioning from traditional manual methods to automated systems that offer enhanced accuracy, reduced time-to-results, and improved clinical outcomes.

The market encompasses various testing methodologies, including conventional culture methods, automated blood culture systems, and molecular diagnostic techniques. Healthcare facilities worldwide rely heavily on blood culture testing as it provides crucial information for appropriate antibiotic therapy selection and patient management strategies.

The increasing prevalence of hospital-acquired infections, rising awareness about early diagnosis of sepsis, and growing emphasis on antimicrobial stewardship programs have positioned blood culture testing as an indispensable tool in modern healthcare. The market includes various stakeholders such as diagnostic laboratories, hospitals, blood banks, and research institutions, all contributing to the expanding demand for reliable and efficient blood culture testing solutions.

Market Dynamics

The global blood culture test market growth is driven by several compelling factors that collectively propel its growth trajectory. The primary driver is the escalating incidence of bloodstream infections and sepsis globally, which has intensified the demand for rapid and accurate diagnostic solutions. The increasing prevalence of hospital-acquired infections, coupled with the growing number of immunocompromised patients due to cancer treatments, organ transplants, and chronic diseases, has created a substantial market demand. Technological advancements in automated blood culture systems, offering faster detection times and improved sensitivity, serve as significant growth catalysts.

Additionally, the growing geriatric population, which is more susceptible to infections, and the increasing number of surgical procedures contribute to market growth. However, the market faces certain restraints including the high cost of automated blood culture systems and their maintenance, which can limit adoption in resource-constrained healthcare settings. The complexity of blood culture procedures requiring skilled laboratory personnel and the risk of contamination leading to false-positive results pose additional challenges. Stringent regulatory requirements for diagnostic devices and the time-consuming nature of traditional culture methods can also impede market growth.

Nevertheless, significant opportunities exist in the development of rapid molecular diagnostic techniques and point-of-care testing solutions that can deliver results within hours rather than days. The expansion of healthcare infrastructure in emerging markets, increasing healthcare expenditure, and the growing focus on personalized medicine present lucrative opportunities. The integration of artificial intelligence and machine learning in blood culture systems for enhanced interpretation and the development of multiplex testing platforms for simultaneous detection of multiple pathogens represent promising avenues for market expansion.

Key Features of the Study

• This report provides in-depth analysis of the global blood culture test market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blood culture test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Becton, Dickinson and Company (BD), bioMerieux S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Roche Diagnostics, Siemens Healthineers AG, Abbott Laboratories, Bruker Corporation, T2 Biosystems Inc., Cepheid Inc., Luminex Corporation, Merck KGaA (MilliporeSigma), Sartorius AG, QIAGEN N.V., and BioFire Diagnostics LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global blood culture test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood culture test market

Market Segmentation

• Method Insights (Revenue, USD Bn, 2020 - 2032)
  • Automated Blood Culture
  • Conventional/Manual Blood Culture
• Product Insights (Revenue, USD Bn, 2020 - 2032)
  • Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
  • Instruments (Automated blood culture systems, laboratory equipment)
  • Software and Services
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Culture-Based Technologies (including conventional, resin-based)
  • Molecular Technologies (NAAT, PCR-based panels, Microarrays)
  • Proteomic Technologies (MALDI-TOF, LC-MS)
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Bacterial Infections (e.g., bacteremia, septicemia)
  • Fungal Infections (e.g., fungemia)
  • Mycobacterial Infections
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Laboratories
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Becton, Dickinson and Company (BD)
  • bioMerieux S.A.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Bruker Corporation
  • T2 Biosystems Inc.
  • Cepheid Inc.
  • Luminex Corporation
  • Merck KGaA (MilliporeSigma)
  • Sartorius AG
  • QIAGEN N.V.
  • BioFire Diagnostics LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Blood Culture Test Market, By Method
  • Global Blood Culture Test Market, By Product
  • Global Blood Culture Test Market, By Technology
  • Global Blood Culture Test Market, By Application
  • Global Blood Culture Test Market, By End User
  • Global Blood Culture Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Blood Culture Test Market, By Method, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Automated Blood Culture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Conventional/Manual Blood Culture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Blood Culture Test Market, By Product, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Instruments (Automated blood culture systems, laboratory equipment)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Software and Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Blood Culture Test Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Culture-Based Technologies (including conventional, resin-based)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Molecular Technologies (NAAT, PCR-based panels, Microarrays)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Proteomic Technologies (MALDI-TOF, LC-MS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Blood Culture Test Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Bacterial Infections (e.g., bacteremia, septicemia)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fungal Infections (e.g., fungemia)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mycobacterial Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Blood Culture Test Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Blood Culture Test Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Becton, Dickinson and Company (BD)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bruker Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• T2 Biosystems Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Luminex Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA (MilliporeSigma)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sartorius AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN N.V.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioFire Diagnostics LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us